ENERZAIR BREEZHALER 114/46/68 indacaterol/glycopyrronium/mometasone furoate 114/46/68 microgram powder for inhalation in capsule with inhaler Australia - English - Department of Health (Therapeutic Goods Administration)

enerzair breezhaler 114/46/68 indacaterol/glycopyrronium/mometasone furoate 114/46/68 microgram powder for inhalation in capsule with inhaler

novartis pharmaceuticals australia pty ltd - glycopyrronium bromide, quantity: 63 microgram (equivalent: glycopyrronium, qty 50 microgram); mometasone furoate, quantity: 80 microgram; indacaterol acetate, quantity: 173 microgram (equivalent: indacaterol, qty 150 microgram) - capsule, hard - excipient ingredients: lactose monohydrate; magnesium stearate - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

ONBREZ BREEZHALER 150 MCG Israel - English - Ministry of Health

onbrez breezhaler 150 mcg

novartis israel ltd - indacaterol as maleate - inhalation powder hard capsules - indacaterol as maleate 150 mcg - indacaterol - maintenance of bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (copd).

ULTIBRO BREEZHALER 11050 MCG Israel - English - Ministry of Health

ultibro breezhaler 11050 mcg

novartis israel ltd - glycopyrronium as bromide; indacaterol as maleate - inhalation powder hard capsules - indacaterol as maleate 110 mcg; glycopyrronium as bromide 50 mcg - indacaterol - ultibro breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).